Benzyltrimethylammonium chloride was not mutagenic to Salmonella typhimurium, TA100, TA1535, TA98, TA1537 and Escherichia coli WP2 uvrA, with or without an exogeneous metabolic activation system.
Benzyltrimethylammonium chloride slightly increased incidences of structural chromosomal aberrations with an exogeneous metabolic activation system.
Purity | : | 98% |
Test species/strain | : | Rats/Crj:CD (SD) |
Test method | : | Guidelines for 28-day Repeated Dose Toxicity Testing of Chemicals (Japan) |
Route | : | Oral |
Doses | : | 0 (vehicle), 30, 60, 120 mg/kg/day |
Vehicle | : | Water |
Number of animals/group | : | Males, 5; females, 5 |
Administration period | : | Males and females, 28 days |
Terminal kill | : | Males and females, days 29 or 43 |
GLP | : | Yes |
Test results:
Purity | : | > 99.0% |
Test species/strains | : | S. typhimurium TA100, TA1535, TA98, TA1537, E. coli WP2 uvrA |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Procedures | : | Pre-incubation method |
Solvent | : | D.W. |
Positive controls | : | -S9 mix, AF-2 (TA100, TA98 and WP2 uvrA), Sodium azide (TA1535), 9-Aminoacridine (TA1537) +S9 mix, 2-Aminoanthracene (all strains) |
Doses | : | 156, 313, 625, 1250, 2500, 5000 μg/plate |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 3 |
Number of replicates | : | 2 |
GLP | : | Yes |
Genetic effects:
S. typhimurium TA100, TA1535, TA98 and TA1537
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] |
E. coli WP2 uvrA
+ | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [ ] | [*] |
Purity | : | > 99.0% |
Type of cell used | : | Chinese hamster lung (CHL) cells |
Test method | : | Guidelines for Screening Mutagenicity Testing of Chemicals (Japan) |
Solvent | : | Physiological saline |
Positive controls | : | long-term treatment; Mitomycin C (24 h and 48 h) short-term treatment; Cyclophosphamide (+S9 and -S9 mix) |
Doses | : | long-term treatment; 475, 950, 1900 μg/ml (24 h and 48 h) short-term treatment; 475, 950, 1900 μg/ml (+S9 and -S9 mix) short-term treatment; 1000, 1300, 1600, 1900 μg/ml (+S9 mix; confirmative examination) |
S9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
Plates/test | : | 2 |
GLP | : | Yes |
clastogenicity | polyploidy | |||||
+ | ? | - | + | ? | - | |
Without metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
With metabolic activation: | [ ] | [*] | [ ] | [ ] | [ ] | [*] |
1) | The tests were performed by the Biosafety Research Center, Foods, Drugs and Pesticides (An-pyo Center), Japan, 582-2 Shioshinden Arahama, Fukude-cho, Iwata-gun, Shizuoka, 437-12, Japan. Tel +81-538-58-1266 Fax +81-538-58-1393 |